Sciclone Pharma (SCLN) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	130.11M
Short-term investments
Accounts receivable	37.75M
Inventories	13.75M
Prepaid expenses and other current assets	2.53M
Deferred tax asset
Total current assets	184.24M
Property and equipment, net	1.83M
Restricted investments
Intangible assets, net
Goodwill	32.1M
Other assets
Total assets	233.36M
Accounts payable	4.74M
Accrued and other current liabilities	19.88M
Total current liabilities
Long-term borrowing on line of credit
Liability for contingent consideration
Deferred tax liability
Other long-term liabilities
Commitments and contingencies	0
Preferred stock; $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 58,221,778 and 48,011,235 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	51K
Additional paid-in capital	301.43M
Accumulated other comprehensive income	1.36M
Accumulated deficit	-94.18M
Total stockholders' equity	208.67M
Total liabilities and stockholders' equity	233.36M

Entities mentioned with SCLN

View All Entities